Laparoscopic ileal interposition with diverted sleeve gastrectomy for treatment of type 2 diabetes

Diabetes and Metabolic Syndrome: Clinical Research and Reviews

Volumn 6, Issue 3, 2012, Pages 125-131

  Kota, Sunil Kumar ^a   Ugale, Surendra ^b   Gupta, Neeraj ^a,b   Modi, Kirtikumar D ^a  

^a Medwin Hospital   (India)

^b Kirloskar Hospital   (India)

Author keywords

Diabetes mellitus; Diverted sleeve gastrectomy; Foregut and hindgut theories; Ileal interposition

Indexed keywords

C PEPTIDE; CALCIUM; CHOLESTEROL; CYANOCOBALAMIN; GLUCOSE; HEMOGLOBIN A1C; INSULIN; IRON; LOW DENSITY LIPOPROTEIN CHOLESTEROL; ORAL ANTIDIABETIC AGENT; TRIACYLGLYCEROL;

ABDOMINAL PAIN; ADULT; AGE; AGED; APPETITE DISORDER; ARTICLE; BODY MASS; CALCIUM BLOOD LEVEL; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CYANOCOBALAMIN DEFICIENCY; DIABETIC PATIENT; DIET RESTRICTION; DISEASE CONTROL; DISEASE DURATION; DIVERTED SLEEVE GASTRECTOMY; DYSLIPIDEMIA; FEMALE; FOLLOW UP; GASTRECTOMY; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; HYPERTENSION; INSULIN TREATMENT; IRON BLOOD LEVEL; LAPAROSCOPIC ILEAL INTERPOSITION; LAPAROSCOPIC SURGERY; MALE; METABOLIC SYNDROME X; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; POSTOPERATIVE COMPLICATION; POSTOPERATIVE NAUSEA; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; REMISSION; SMALL INTESTINE PERFORATION; STOMACH DISTENSION; TREATMENT OUTCOME; TRIACYLGLYCEROL BLOOD LEVEL; VITAMIN BLOOD LEVEL; WEIGHT REDUCTION;

ADULT; AGED; ALBUMINURIA; BLOOD GLUCOSE; BODY MASS INDEX; DIABETES MELLITUS, TYPE 2; DYSLIPIDEMIAS; FEASIBILITY STUDIES; FEMALE; FOLLOW-UP STUDIES; GASTROPLASTY; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; ILEUM; INDIA; LAPAROSCOPY; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY; PROSPECTIVE STUDIES; REMISSION INDUCTION; TREATMENT OUTCOME; WEIGHT LOSS;

EID: 84869488878     PISSN: 18714021     EISSN: 18780334     Source Type: Journal    
DOI: 10.1016/j.dsx.2012.09.014     Document Type: Article

References (53)

1. F.G. Banting, and C.H. Best The internal secretion of the pancreas The Journal of Laboratory and Clinical Medicine 7 1922 251 266
2. G.M. Reaven Banting lecture 1988: role of insulin resistance in human disease Diabetes 37 1988 1595 1607
3. American Diabetes Association Prevention or delay of type 2 diabetes Diabetes Care 27 Suppl. 2004 S47 S53
4. J.E. Shaw, R.A. Sicree, and P.Z. Zimmet Global estimates for the prevalence of diabetes for 2010 & 2030 Diabetes Research and Clinical Practice 87 2010 4 14
5. S.R. Joshi, A.K. Das, V.J. Vijay, and V. Mohan Challenges in diabetes care in India: sheer numbers. Lack of awareness and inadequate control Journal of the Association of Physicians of India 56 2008 443 450
6. S. Bjork, A. Kapur, H. King, J. Nair, and A. Ramachandran Global policies: aspects of diabetes in India Health Policy 66 2003 61 72
7. World Health organization. Obesity and Overweight, Factsheet no. 311, available [online] from: http://www. who.int/mediacentre/factsheets/fs311/en/ index.html.
8. S.E. Greenway, F.L. Greenway 3rd, and S. Klein Effects of obesity surgery on non insulin dependent diabetes mellitus Archives of Surgery 137 2002 1109 1117
9. H. Buchwald, R. Estok, K. Fahrbach, D. Banel, M.D. Jensen, and W.J. Pories Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis American Journal of Medicine 122 2009 248 256
10. A. Patriti, E. Facchiano, C. Annetti, M.C. Aisa, F. Galli, and C. Fanelli Early improvement of glucose tolerance after ileal transposition in a non-obese type 2 diabetes rat model Obesity Surgery 15 2005 1258 1264
11. A.D. Strader, T.P. Vahl, R.J. Jandacek, S.C. Woods, D.A. D'Alessio, and R.J. Seeley Weight loss through ileal transposition is accompanied by increased ileal hormone secretion and synthesis in rats American Journal of Physiology Endocrinology and Metabolism 288 2005 E447 E453
12. A.L. De Paula, A.L.V. Macedo, N. Rassi, C.A. Machado, V. Schraibman, and L.Q. Silva Laparoscopic treatment of type 2 diabetes mellitus for patients with a body mass index less than 35 Surgical Endoscopy 22 2008 706 716
13. A.L. De Paula, A.L. Macedo, N. Rassi, S. Vencio, C.A. Machado, and B.R. Mota Laparoscopic treatment of metabolic syndrome in patients with type 2 diabetes mellitus Surgical Endoscopy 22 2008 2670 2678
14. K.V.S. Hari Kumar, S. Ugale, N. Gupta, V. Naik, P. Kumar, and P. Bhaskar Ileal transposition with sleeve gastrectomy for control of type 2 diabetes Diabetes Technology and Therapeutics 11 2009 1 5
15. A. Tinoco, L. El-Kadre, R. Tinoco, and P. Savasi-Rocha Short-term and mid-term control of type 2 diabetes mellitus by laparoscopic sleeve gastrectomy with ileal interposition World Journal of Surgery 35 2011 2238 2244
16. S. Kumar Kota, S. Ugale, N. Gupta, V. Naik, S. Krishna Kota, and K.V.S. Hari Kumar Remission of type 2 diabetes mellitus by ileal interposition with sleeve gastrectomy Indian Journal of Endcrinology and Metabolism 9 2011 374 381
17. S.K. Kota, S. Ugale, N. Gupta, V. Naik, K.V. Kumar, and K.D. Modi Ileal interposition with sleeve gastrectomy for treatment of type 2 diabetes mellitus Indian Journal of Endcrinology and Metabolism 16 2012 589 598
18. A.L. DePaula, A.L. Macedo, B.R. Mota, and V. Schraibman Laparoscopic ileal interposition associated to a diverted sleeve gastrectomy is an effective operation for the treatment of type 2 diabetes mellitus patients with BMI 21-29 Surgical Endoscopy 23 2009 1313 1320
19. 2 Surgery for Obesity and Related Diseases 6 2010 296 305
20. American Diabetes Association Diagnosis and classification of diabetes mellitus Diabetes Care 33 Suppl. 1 2010 62 69
21. G. Eknoyan Quetlet A (1796-1874). The average man and indices of obesity Nephrology, Dialysis, Transplantation 23 2008 47 51
22. A. Misra, P. Chowbey, B.M. Makkar, N.K. Vikram, J.S. Wasir, and D. Chadha Consensus statement for diagnosis of obesity, abdominal obesity and metabolic syndrome for Asian Indians and recommendations for physical activity, medical and surgical management Journal of the Association of Physicians of India 57 2009 163 170
23. D.W. Cockroft, and M.H. Gault Prediction of creatinine clearance from serum creatinine Nephron 16 1976 31 41
24. M.H. Gault, L.L. Longerich, J.D. Harnett, and C. Wesolowski Predicting glomerular function from adjusted serum creatinine Nephron 62 1992 249 256
25. R.C. Turner, R.R. Holman, D. Matthews, T.D. Hockaday, and J. Peto Insulin deficiency and insulin resistance interaction in diabetes: estimation of their relative contribution by feedback analysis from basal plasma insulin and glucose concentrations Metabolism: Clinical and Experimental 28 1979 1086 1096
26. American Diabetic Association Executive summary: standards of medical care in diabetes - 2010 Diabetes Care 33 2010 S4 S10
27. American Diabetic Association Standard of medical care in diabetes - 2009 Diabetes Care 32 Suppl. 1 2009 S13 S61
28. S.R. Joshi, A.K. Das, V.J. Vijay, and V. Mohan Challenges in diabetes care in India: sheer numbers, lack of awareness and inadequate control Journal of the Association of Physicians of India 56 2008 443 450
29. H. Buchwald, Y. Avidor, E. Braunwald, M.D. Jensen, W. Pories, and K. Fahrbach Bariatric surgery: a systematic review and meta-analysis JAMA 292 2004 1724 1737
30. F. Broglio, E. Arvat, A. Benso, C. Gottero, G. Muccioli, and M. Papotti Ghrelin, a natural GH secretagogue produced by the stomach, induces hyperglycemia and reduces insulin secretion in humans Journal of Clinical Endocrinology and Metabolism 86 2001 5083 5086
31. A.L. DePaula, A.L. Macedo, V. Schraibman, B.R. Mota, and S. Vencio Hormonal evaluation following laparoscopic treatment of type 2 diabetes mellitus patients with BMI 20-34 Surgical Endoscopy 23 2009 1724 1732
32. J.J. Holst The physiology of glucagon-like peptide 1 Physiological Reviews 87 2007 1409 1439
33. L.L. Kjems, J.J. Holst, A. Volund, and S. Madsbad The influence of GLP-1 on glucose stimulated insulin secretion: effects on beta-cell sensitivity in type 2 and nondiabetic subjects Diabetes 52 2003 380 386
34. D.J. Drucker Enhancing incretin action for the treatment of type 2 diabetes Diabetes Care 26 2003 2929 2940
35. N. Irwin, V.A. Gault, B.D. Green, B. Greer, J.T. McCluskey, and P. Harriott Effects of short-term chemical ablation of the gip receptor on insulin secretion Biological Chemistry 385 2004 845 852
36. V.A. Gault, N. Irwin, B.D. Green, J.T. McCluskey, B. Greer, and C.J. Bailey Chemical ablation of gastric inhibitory polypeptide receptor action by daily (Pro3) GIP administration improves glucose tolerance and ameliorates insulin resistance and abnormalities of islet structure in obesity-related diabetes Diabetes 54 2005 2436 2446
37. E. Ferrannini, and C. Cobelli The kinetics of insulin in man. General aspects Diabetes Metabolism and Review 3 1987 335 363
38. T. Vilsboll, and J.J. Holst Incretins: insulin secretion and type 2 diabetes mellitus Diabetologia 47 2004 357 366
39. F. Rubino, and J. Marescaux Effect of duodenal-jejunal exclusion in a non-obese animal model of type 2 diabetes: a new perspective for an old disease Annals of Surgery 239 2004 1 11
40. J.J. Meier, B. Gallwitz, N. Siepmann, J.J. Holst, C.F. Deacon, and W.E. Schmidt Gastric inhibitory polypeptide (GIP) dose-dependently stimulates glucagon secretion in healthy human subjects at euglycaemia Diabetologia 46 2003 798 801
41. R.N. Kulkarni GIP: no longer the neglected incretin twin? Science Translational Medicine 2 2010 49ps47
42. N. Irwin, and P.R. Flatt Evidence for beneficial effects of compromised gastric inhibitory polypeptide action in obesity-related diabetes and possible therapeutic implications Diabetologia 52 2009 1724 1731
43. R. Saxena, M.F. Hivert, C. Langenberg, T. Tanaka, J.S. Pankow, and P. Vollenweider Genetic variation in GIPR influences the glucose and insulin responses to an oral glucose challenge Nature Genetics 42 2010 142 148
44. E.K. Speliotes, C.J. Willer, S.I. Berndt, K.L. Monda, ThorleifssonG, and A.U. Jackson Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index Nature Genetics 42 2010 937 948
45. E.N. Hansen, R.A. Tamboli, J.M. Isbell, J. Saliba, J.P. Dunn, and P.A. Marks-Shulman Role of the foregut in the early improvement in glucose tolerance and insulin sensitivity following Roux-en-Y gastric bypass surgery American Journal of Physiology Gastrointestinal and Liver Physiology 300 2011 G795 G802
46. P.W. Maljaars, H.P. Peters, D.J. Mela, and A.A. Masclee Ileal brake: a sensible food target for appetite control. A review Physiology and Behavior 95 2008 271 281
47. M.E. Patti, S.M. Houten, A.C. Bianco, R. Bernier, P.R. Larsen, and J.J. Holst Serum bile acids are higher in humans with prior gastric bypass: potential contribution to improved glucose and lipid metabolism Obesity 179 2009 1671 1677
48. T. Claudel, B. Staels, and F. Kuipers The farnesoid X receptor: a molecular link between bile acid and lipid and glucose metabolism Arteriosclerosis, Thrombosis, and Vascular Biology 25 2005 2020 2031
49. J. Prawitt, S. Caron, and B. Staels Bile acid metabolism and the pathogenesis of type 2 diabetes Current Diabetes Reports 11 2011 160 166
50. J. Thulesen, B. Hartmann, H. Kissow, P.B. Jeppesen, C. Orskov, and J.J. Holst Intestinal growth adaptation and GLP-2 in rats with ileal-jejunal transposition or small bowel resection Digestive Diseases and Sciences 46 2001 379 388
51. G.J. Service, G.B. Thompson, J. Service, J.C. Andrews, M.L. Collazo-Clavell, and R.V. Lloyd Hyperinsulinemic hypoglycemia with nessidioblastosis after gastric-bypass surgery New England Journal of Medicine 353 2005 249 252
52. M. DiGiorgi, D.J. Rosen, J.J. Choi, L. Milone, B. Schrope, and L. Olivero-Rivera Re-emergence of diabetes after gastric bypass in patients with mid to long term follow-up Surgery for Obesity and Related Diseases 6 2010 249 253
53. S.M. Chikunguwo, L.G. Wolfe, P. Dodson, J.G. Meador, N. Baugh, and J.N. Clore Analysis of factors associated with durable remission of diabetes after Roux- en- Y gastric bypass Surgery for Obesity and Related Diseases 6 2010 254 259